Skip to main content
Elsevier (RELX)

Elsevier (RELX)

Elsevier is a global academic and professional publisher that provides scholarly journals, books, and digital products for science and healthcare. It offers databases and tools such as Scopus, ScienceDirect, and ClinicalKey that support research, publishing, and clinical decision-making, and is a subsidiary of the RELX Group.www.elsevier.com

Search complete. 62 mentions across 36 episodes found for "Elsevier (RELX)".

Sep 10, 2026

Jane DwelleyHOST
0:35
Welcome to the Global Leaders Podcast from Chime International, recorded live at the Health Europe Exhibition in Amsterdam.
Jane DwelleyHOST
0:43
And I am so thrilled now to have two people here from Elsevier.
Jane DwelleyHOST
0:48
And I'm going to ask them to introduce themselves to get the conversation going.
Jane DwelleyHOST
0:51
So let's start with you.
Richard DanielsGUEST
1:07
My name is Richard Daniels.
Richard DanielsGUEST
1:09
I'm a paediatrician.
Richard DanielsGUEST
1:09
I work in a large London hospital and I sit on the Elsevier European Advisory Physician Board.
Richard DanielsGUEST
1:16
I've got a parallel career in digital health.
Lindsay SmithHOST
0:00
[upbeat music] Hi, I'm Lindsay Smith welcoming you to Raise the Line from Elsevier, an ongoing exploration about how to improve health and healthcare.
Lindsay SmithHOST
0:13
Our guest today has spent her career asking a question that's often overlooked, and sometimes actively avoided in a healthcare system that tends to reward action over restraint.
Lindsay SmithHOST
0:24
Does this test or treatment actually help patients? And how do we know? Dr.
Yolandi de WeerdtHOST
0:12
Welcome everyone to the Emerge AI in Business podcast.
Yolandi de WeerdtHOST
0:16
Today's guest is Red Alden, Chief Technology Officer at Elsevier Health Markets.
Yolandi de WeerdtHOST
0:20
Red discusses why transparency and claim level validation, tracing every AI-generated assertion back to peer-reviewed sources, are essential to earning clinician trust in generative AI.
Yolandi de WeerdtHOST
0:31
He also explains how healthcare institutions are standing up cross-functional governance boards modeled on clinical trial review structures to evaluate risk and oversight as regulation continues to lag behind the technology.
Yolandi de WeerdtHOST
0:43
A quick note for our audience that the views and opinions expressed by Red on today's program are his own and do not reflect those of Elsevier Health Markets or its leadership.
Yolandi de WeerdtHOST
0:51
Getting in front of enterprise AI buyers is not about impressions, it's about trust.
Yolandi de WeerdtHOST
0:55
At Emerge, we help AI vendors engage decision makers through research-driven content and conversations that actually matter in the buying process.
Rhett AldenGUEST
5:25
States are trying to regulate it.
Allen W. HeinemannGUEST
14:42
ACRM staff leadership and elected leadership also had important input in that role, as did the Our consideration of the interdisciplinary special interest groups, activities, and the size of them and their importance to the organization.
Allen W. HeinemannGUEST
14:55
But also important is our publisher, Elsevier, for whom we need to develop a business plan and to share the details with them and get their sign-off.
Allen W. HeinemannGUEST
15:05
So it's really validating to get their interest in these topics as well.
Leighton ChanGUEST
15:09
They do their due diligence.
Leighton ChanGUEST
15:11
Elsevier is a very thorough and robust company, and they did their due diligence around the topic.
Helen HonigGUEST
15:17
In particular for the new cancer rehab, and I don't think I have the title perfect, and chronic disease journal, which you would think I'd have that down pat.
Helen HonigGUEST
15:27
But in part, that is reflective of our thought on how to best put cancer.
Allen W. HeinemannGUEST
19:11
So
Matthew BrowneHOST
21:15
...
Matthew BrowneHOST
21:15
in, in, in that whole process, right? It would've been the business people or managers working for Elsevier or whatever the big journal conglomerate is-
Chris KavanaghHOST
21:22
Elsevier, yes
Matthew BrowneHOST
21:24
... that, that, that, that owns nature.
Matthew BrowneHOST
21:26
That's the ed- editorial stuff, and then you have some journalists and so on.
Krishna ChoudharyHOST
5:52
So by the end of the episode, you should be able to fully understand this graphic.
Krishna ChoudharyHOST
5:57
So whenever you publish in the Elsevier journals, which is like neuron, cell, they make you do not just a normal graph, a normal abstract.
Krishna ChoudharyHOST
6:09
Every journal has an abstract, right? You do the abstract and then your main paper.
Krishna ChoudharyHOST
6:12
Being
Lester NareHOST
6:13
like a block of executive summary in text.
Krishna ChoudharyHOST
6:15
Yes, in text.
Krishna ChoudharyHOST
6:18
So Elsevier journals also have a graphical abstract where they've got like a pictorial... way of showing what exactly is happening.
Krishna ChoudharyHOST
6:28
And my goal today is to explain that graphical abstract in a lot of detail.
Jon LindbergGUEST
4:37
Because of Dr. Basford's tremendous success and because of the success of the archives, you know, we talk with our publisher.
Jon LindbergGUEST
4:44
Our publisher is Elsevier.
Jon LindbergGUEST
4:45
the biggest, greatest publisher in the history of the world.
Jon LindbergGUEST
4:49
Really, they are absolutely fantastic.

19 MINS LATER

Jon LindbergGUEST
23:47
And we found just some absolutely tremendous resources globally.
Jon LindbergGUEST
23:51
We ended up contracting with Wiley Publishing Services.
Jon LindbergGUEST
23:55
Now, they are owned by Wiley Publishing, which is a competitor to Elsevier, but we've been guaranteed and assured that there's a strong firewall.
Jon LindbergGUEST
24:04
Wiley Publishing Services has just a fantastic history And I went down and met, uh, with those people.
Tom AllenHOST
16:33
Penny, thank you to you, the audience, for joining us today on this episode of Control Lead.
Tom AllenHOST
16:39
We have many more fantastic episodes and guests coming up, including Jill Luber, CTO at Elsevier, and speakers from the South Central Ambulance Service.
Tom AllenHOST
16:49
as well as IBM later on in the month.
Tom AllenHOST
16:52
So please do stay tuned for those.
Monique CraigGUEST
46:16
have a context.
Monique CraigGUEST
46:17
Contextual knowledge is by touching and doing things and observing, not just by writing tons of paper so you're in a hurry, you know? And I see a lot of paper on the horse stuff, and I'm like, someone wrote, and it's on Elsevier, wrote a paper of the effect of dehydration, forceful dehydration on horses.
Monique CraigGUEST
46:35
And I was like, who on earth would think of writing a paper like that? You're insane.
Monique CraigGUEST
46:40
You know, and sometimes I feel, I'm like, how did you get funding for this? But I don't do that with...
Lindsay SmithHOST
0:09
Hi, I'm Lindsay Smith welcoming you to Raise the Line from Elsevier, an ongoing exploration about how to improve health and healthcare.
Lindsay SmithHOST
0:18
For millions of young women and girls, often the first place they turn with questions about their bodies isn't a doctor's office.
Lindsay SmithHOST
0:25
It's social media.

30 MINS LATER

Lindsay SmithHOST
30:03
outcomes.
Lindsay SmithHOST
30:04
I appreciate your honesty about both the progress and the distance still to go in health equity.
Lindsay SmithHOST
30:10
I want to shift gears slightly and talk about Elsevier a little bit.
Lindsay SmithHOST
30:14
So at Elsevier, we are an education company at heart, and we're always hunting for knowledge gaps to fill, to find out what people aren't talking about enough.
Lindsay SmithHOST
30:23
So I'd like to ask you, is there a topic you wish we'd make a video on, something that you think deserves more attention?

26 more episodes mention Elsevier (RELX).

Create an account to see the whole feed, search across every transcript, and follow the entities you care about.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.